Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
"Waitlist mortality" is high for myeloma patients with limited access to BCMA therapy.
Ahmed N, Wesson W, Mushtaq MU, Bansal R, AbdelHakim H, Bromert S, Appenfeller A, Ghazal BA, Singh A, Abhyankar S, Ganguly S, McGuirk J, Abdallah AO, Shune L. Ahmed N, et al. Among authors: abdelhakim h. Front Oncol. 2023 Aug 3;13:1206715. doi: 10.3389/fonc.2023.1206715. eCollection 2023. Front Oncol. 2023. PMID: 37601685 Free PMC article.
A Phase I Study to Evaluate Two Doses of Wharton's Jelly-Derived Mesenchymal Stromal Cells for the Treatment of De Novo High-Risk or Steroid-Refractory Acute Graft Versus Host Disease.
Soder RP, Dawn B, Weiss ML, Dunavin N, Weir S, Mitchell J, Li M, Shune L, Singh AK, Ganguly S, Morrison M, Abdelhakim H, Godwin AK, Abhyankar S, McGuirk J. Soder RP, et al. Among authors: abdelhakim h. Stem Cell Rev Rep. 2020 Oct;16(5):979-991. doi: 10.1007/s12015-020-10015-8. Stem Cell Rev Rep. 2020. PMID: 32740891 Free PMC article. Clinical Trial.
Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
Mushtaq MU, Shahzad M, Chaudhary SG, Luder M, Ahmed N, Abdelhakim H, Bansal R, Balusu R, DeJarnette S, Divine C, Kribs R, Shune L, Singh AK, Ganguly S, Abhyankar SH, McGuirk JP. Mushtaq MU, et al. Among authors: abdelhakim h. Transplant Cell Ther. 2021 Sep;27(9):796.e1-796.e7. doi: 10.1016/j.jtct.2021.07.005. Epub 2021 Jul 10. Transplant Cell Ther. 2021. PMID: 34256172 Free PMC article.
Lessons learned from COVID-19 pandemic: outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipients.
Al-Ramahi JS, Shahzad M, Li K, DeJarnette S, Chaudhary SG, Lutfi F, Ahmed N, Balusu R, Bansal R, Abdelhakim H, Shune L, Singh AK, Abhyankar SH, McGuirk JP, Mushtaq MU. Al-Ramahi JS, et al. Among authors: abdelhakim h. Leuk Lymphoma. 2023 Dec;64(12):1981-1991. doi: 10.1080/10428194.2023.2243355. Epub 2023 Aug 13. Leuk Lymphoma. 2023. PMID: 37574842
Results of the First Clinical Study in Humans That Combines Hyperbaric Oxygen Pretreatment with Autologous Peripheral Blood Stem Cell Transplantation.
Abdelhakim H, Shune L, Bhatti S, Cantilena AR, Baran A, Lin TL, Ganguly S, Singh AK, Abhyankar S, Divine C, Lipe B, McGuirk J, Allin D, Aljitawi OS. Abdelhakim H, et al. Biol Blood Marrow Transplant. 2019 Sep;25(9):1713-1719. doi: 10.1016/j.bbmt.2019.05.028. Epub 2019 Jun 3. Biol Blood Marrow Transplant. 2019. PMID: 31170519 Free article. Clinical Trial.
Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation.
Al-Ramahi JS, Shahzad M, Nguyen A, Li K, Amin MK, Ahmed N, Lutfi F, DeJarnette S, Chaudhary SG, Bansal R, Abdelhakim H, Shune L, Abdallah AO, Singh AK, Abhyankar SH, McGuirk JP, Mushtaq MU. Al-Ramahi JS, et al. Among authors: abdelhakim h. Bone Marrow Transplant. 2024 Jan;59(1):134-137. doi: 10.1038/s41409-023-02125-x. Epub 2023 Oct 13. Bone Marrow Transplant. 2024. PMID: 37833526 No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 36164215
38 results